Biotech Startups

Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.

1 investor

Citrus Health Group is a healthcare communications agency that provides scientific, clinical, and commercialization support to biopharmaceutical companies bringing new assets to market. It offers services including medical communications, commercialization strategy, market access, and launch planning across therapeutic areas such as oncology and rare diseases.

1 investor

Civetbio is a Chinese biotechnology company supporting research and development of live biotherapeutic products. Its offering combines a microbiota bank, a clinical intervention platform and a bioinformatics pipeline built on large datasets, giving researchers resources to study Asian gut microbiome profiles and how they differ by region.

1 investor

1 investor

Clara Health operates a decentralized clinical trial platform that connects patients with clinical studies and provides 24/7 patient navigators to guide them through matching, scheduling, insurance, and paperwork at no cost. It also helps trial sponsors reach diverse and representative patient populations beyond physical trial sites; the company has been acquired by clinical research organization M&B Sciences Inc.

1 investor

Clarion Healthcare is a consulting firm that provides commercialization strategy services to life sciences and pharmaceutical companies across therapeutic areas and the product life cycle. Its consultants advise on asset, portfolio, and corporate-level decisions to support drug development and commercial launch.

1 investor

Claris Ventures SGR is an Italy-based venture capital firm founded in 2019 that invests in early-stage biopharma companies emerging from the Italian life sciences research ecosystem. Through its Claris Biotech I fund, it backs new companies developing drugs targeting unmet patient needs.

1 investor

Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company developing targeted therapies and imaging products for cancer treatment in children and adults.

1 investor

Clarivate is a global provider of enriched data, insights, analytics, workflow solutions and expert services serving academia, government, intellectual property, and life sciences sectors. The company serves universities, pharma companies, biotech firms, medtech organizations, and R&D enterprises across 180+ countries.

1 investor

Clean Chemistry develops oxidation-based water treatment chemistries for microbial control, water clarification, recycling and disposal across industries including energy, pulp and paper, food and beverage, and cooling towers. Its products aim to reduce fresh water use, remove contaminants, and lower operating costs compared to traditional oxidizers.

1 investor

Clearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).

1 investor

ClearPoint Neuro develops neurosurgical guidance systems and platforms that enable precise navigation to the brain and spine for device, cell, and gene therapy procedures. The company serves neurosurgery centers and supports clinical drug delivery trials through live MRI-guided and image-guided technology.

1 investor

ClearSight Therapeutics develops over-the-counter ophthalmic products for common eye conditions such as dry eye, contact lens dryness, and conjunctivitis, working within FDA OTC monograph pathways. Its formulations aim to support ocular surface lubrication and moisture retention for consumers experiencing eye discomfort.

1 investor

Cleveland Diagnostics develops blood-based cancer diagnostic tests using its IsoClear platform, which measures structural changes in proteins to identify whether biomarkers came from cancer cells. Its first test, IsoPSA, targets prostate cancer detection to reduce unnecessary biopsies.

1 investor

Clever Leaves develops cannabis products and services across the supply chain, from raw materials to finished products, for licensed pharmaceutical companies seeking market access acceleration.

1 investor

ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.

1 investor

Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis. It connects users with licensed providers who can prescribe treatment upon a positive result, aimed at consumers managing their sexual health without visiting a clinic.

1 investor

ClickBio manufactures laboratory automation hardware and reagent handling equipment for life sciences research, including reagent reservoirs, fill stations, and plate adapters compatible with standard microplate formats.

1 investor

Climb Bio develops monoclonal antibody therapies for immune-mediated diseases, advancing clinical-stage candidates such as budoprutug for conditions including immune thrombocytopenia. Its investigational therapies target patients with limited treatment options.

1 investor

Clinovo provides staff augmentation services for pharmaceutical and biotech sponsors, embedding specialized clinical research professionals such as CRAs, data managers, and regulatory specialists directly into sponsor teams on a flexible basis. The company serves clinical trial sponsors seeking to scale internal teams with regulated expertise without permanent hiring overhead.

1 investor

CLLEVERT develops laboratory instrumentation and diagnostic technology solutions, with expertise in biochemistry, materials science, and clinical diagnostics. The company transforms advanced research into practical laboratory equipment and methods for improved efficiency and sustainability.

1 investor

Clover Biopharma is a commercial-stage biotechnology company that develops vaccines using its Trimer-Tag technology platform along with in-house manufacturing and commercial capabilities. Its pipeline focuses on respiratory vaccine candidates, including RSV, hMPV, and PIV3 combinations, for populations worldwide.

1 investor

Cloverleaf Bio is developing engineered tRNA therapeutics for oncology, designed to inhibit multiple enzymes required for cancer growth from a single molecule. The company focuses on cancer treatment within the biotech and therapeutics space.

1 investor

Clyde Biosciences is a contract research organization offering predictive cardiac safety and efficacy testing using human iPSC-derived cardiomyocyte models, aimed at pharmaceutical and biotech teams assessing cardiotoxicity for clinical translation. It provides functional cardiac safety data aligned with regulatory guidance, including the CiPA Assay.

1 investor